“…95,96 Matsui et al 97 studied patients with severe cardiomyopathy, and found that after 6 months of optimal medical therapy, a worsening H/M had, with BNP, the highest predictive value for CD, suggesting that such patients may have benefited from earlier device therapy or transplant. At the same time, a recent study by Drakos et al 98 of patients with an LVAD found that clinical improvement paralleled improvement in tracer uptake, suggesting that 123 ImIBG could guide which patients need transplant, or instead who might be able to have the device discontinued. Along the same lines, it is reported that a decreased H/M predicted poor response to CRT.…”